103 related articles for article (PubMed ID: 21725619)
21. The miR-134 attenuates the expression of transcription factor FOXM1 during pluripotent NT2/D1 embryonal carcinoma cell differentiation.
Chen Y; Meng L; Yu Q; Dong D; Tan G; Huang X; Tan Y
Exp Cell Res; 2015 Jan; 330(2):442-450. PubMed ID: 25447206
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of mouse embryonic carcinoma cell growth by lidamycin through down-regulation of embryonic stem cell-like genes Oct4, Sox2 and Myc.
Zhen HY; He QH; Zhen YZ; Wang SL; Liu YN; Wu WH; Zhang XY; Lu AL; Shen L
Invest New Drugs; 2011 Dec; 29(6):1188-97. PubMed ID: 20596749
[TBL] [Abstract][Full Text] [Related]
23. Retinoic acid-mediated down-regulation of Oct3/4 coincides with the loss of promoter occupancy in vivo.
Minucci S; Botquin V; Yeom YI; Dey A; Sylvester I; Zand DJ; Ohbo K; Ozato K; Scholer HR
EMBO J; 1996 Feb; 15(4):888-99. PubMed ID: 8631309
[TBL] [Abstract][Full Text] [Related]
24. Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.
Hu J; Dong A; Fernandez-Ruiz V; Shan J; Kawa M; MartÃnez-Ansó E; Prieto J; Qian C
Cancer Res; 2009 Sep; 69(17):6951-9. PubMed ID: 19690140
[TBL] [Abstract][Full Text] [Related]
25. Role for up-regulated ganglioside biosynthesis and association of Src family kinases with microdomains in retinoic acid-induced differentiation of F9 embryonal carcinoma cells.
Sato T; Zakaria AM; Uemura S; Ishii A; Ohno-Iwashita Y; Igarashi Y; Inokuchi J
Glycobiology; 2005 Jul; 15(7):687-99. PubMed ID: 15788739
[TBL] [Abstract][Full Text] [Related]
26. A putative G-protein-coupled receptor, H218, is down-regulated during the retinoic acid-induced differentiation of F9 embryonal carcinoma cells.
Li Y; MacLennan AJ; Rogers MB
Exp Cell Res; 1998 Mar; 239(2):320-5. PubMed ID: 9521849
[TBL] [Abstract][Full Text] [Related]
27. Analysis of Esg1 expression in pluripotent cells and the germline reveals similarities with Oct4 and Sox2 and differences between human pluripotent cell lines.
Western P; Maldonado-Saldivia J; van den Bergen J; Hajkova P; Saitou M; Barton S; Surani MA
Stem Cells; 2005; 23(10):1436-42. PubMed ID: 16166252
[TBL] [Abstract][Full Text] [Related]
28. 9-cis-retinoic acid induces neuronal differentiation of retinoic acid-nonresponsive embryonal carcinoma cells.
Yokota Y; Ohkubo H
Exp Cell Res; 1996 Oct; 228(1):1-7. PubMed ID: 8892963
[TBL] [Abstract][Full Text] [Related]
29. Phosphoglycerate dehydrogenase inhibition induces p-mTOR-independent autophagy and promotes multilineage differentiation in embryonal carcinoma stem-like cells.
Sharif T; Martell E; Dai C; Ghassemi-Rad MS; Lee K; Singh SK; Weaver ICG; Gujar S
Cell Death Dis; 2018 Sep; 9(10):990. PubMed ID: 30250195
[TBL] [Abstract][Full Text] [Related]
30. Differential activity of the FGF-4 enhancer in F9 and P19 embryonal carcinoma cells.
Boer B; Bernadt CT; Desler M; Wilder PJ; Kopp JL; Rizzino A
J Cell Physiol; 2006 Jul; 208(1):97-108. PubMed ID: 16523502
[TBL] [Abstract][Full Text] [Related]
31. The use of two-dimensional gel electrophoresis in studies on the role of cytoskeletal plaque proteins as tumor suppressors.
Ben-Ze'ev A
Electrophoresis; 1996 Nov; 17(11):1752-63. PubMed ID: 8982608
[TBL] [Abstract][Full Text] [Related]
32. [Growth and differentiation of human germ cell tumors: a possible model of embryogenesis].
Sekiya S
Hum Cell; 1995 Mar; 8(1):3-9. PubMed ID: 7669750
[TBL] [Abstract][Full Text] [Related]
33. Telomeric noncoding RNA promotes mouse embryonic stem cell self-renewal through inhibition of TCF3 activity.
Xu X; Guo M; Zhang N; Ye S
Am J Physiol Cell Physiol; 2018 Jun; 314(6):C712-C720. PubMed ID: 29513567
[TBL] [Abstract][Full Text] [Related]
34. T-cell factor 3 regulates embryonic stem cell pluripotency and self-renewal by the transcriptional control of multiple lineage pathways.
Tam WL; Lim CY; Han J; Zhang J; Ang YS; Ng HH; Yang H; Lim B
Stem Cells; 2008 Aug; 26(8):2019-31. PubMed ID: 18467660
[TBL] [Abstract][Full Text] [Related]
35. Growth and Differentiation Factor 3 Is Transcriptionally Regulated by OCT4 in Human Embryonic Carcinoma Cells.
Han MH; Park SW; Do HJ; Chung HJ; Song H; Kim JH; Kim NH; Park KH; Kim JH
Biol Pharm Bull; 2016; 39(11):1802-1808. PubMed ID: 27803451
[TBL] [Abstract][Full Text] [Related]
36. The expression of the embryonic gene Cripto-1 is regulated by OCT4 in human embryonal carcinoma NCCIT cells.
Park SW; Do HJ; Han MH; Choi W; Kim JH
FEBS Lett; 2018 Jan; 592(1):24-35. PubMed ID: 29223130
[TBL] [Abstract][Full Text] [Related]
37. Oct4 regulates the miR-302 cluster in P19 mouse embryonic carcinoma cells.
Liu H; Deng S; Zhao Z; Zhang H; Xiao J; Song W; Gao F; Guan Y
Mol Biol Rep; 2011 Mar; 38(3):2155-60. PubMed ID: 20857206
[TBL] [Abstract][Full Text] [Related]
38. Role of SOX2 in the etiology of embryonal carcinoma, based on analysis of the NCCIT and NT2 cell lines.
Eini R; Stoop H; Gillis AJ; Biermann K; Dorssers LC; Looijenga LH
PLoS One; 2014; 9(1):e83585. PubMed ID: 24404135
[TBL] [Abstract][Full Text] [Related]
39. Ectopic activation of WNT signaling in human embryonal carcinoma cells and its effects in short- and long-term in vitro culture.
Atlasi Y; van Dorsten RT; Sacchetti A; Joosten R; Oosterhuis JW; Looijenga LHJ; Fodde R
Sci Rep; 2019 Aug; 9(1):11928. PubMed ID: 31417131
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of OCT4 promotes differentiation and inhibits growth of BE (2)-C human neuroblastoma I-type cells.
Yang L; Zheng J; Xu T; Xiao X
Oncol Rep; 2013 Jun; 29(6):2191-6. PubMed ID: 23525564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
